Relapse after successful treatment with immunotherapy: lessons for the future.
Fisher
R I
RI
Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL 60153, USA.
D002292:Carcinoma, Renal Cell / Q000209:etiology / Q000628:therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000209:etiology / Q000628:therapy*; D008545:Melanoma / Q000209:etiology / Q000628:therapy*; D009364:Neoplasm Recurrence, Local / Q000209:etiology* / Q000628:therapy; D012878:Skin Neoplasms / Q000209:etiology / Q000628:therapy*; D015996:Survival Rate
D007376:Interleukin-2